Erythropoietin receptor Y479 couples to ERK1/2 activation via recruitment of phospholipase Cgamma

Exp Cell Res. 2005 Sep 10;309(1):1-11. doi: 10.1016/j.yexcr.2005.04.030.

Abstract

Red blood cell development is primarily controlled by erythropoietin (EPO). Several studies have revealed the importance of EPO-R Y343 and Y479 for erythroid cell growth, differentiation, and survival. In order to isolate critical signaling proteins that bind to EPO-R, we initiated a Cloning of Ligand Target (COLT) screen using a murine embryonic day 16 phage library and a biotinylated EPO-R Y343 phosphopeptide. One of the clones isolated encodes Phospholipase C (PLC)gamma1. PLCgamma1 is rapidly tyrosine phosphorylated upon EPO stimulation and associates with EPO-R in an SH2-domain-dependent manner. Although PLCgamma1 bound EPO-R Y343, Y401, Y429, Y431, and Y479 in the COLT screen, PLCgamma1 required Y479 for association with EPO-R in Ba/F3-EPO-R cells. Studies have identified EPO-R Y479 as important for ERK activation. Since PI3-kinase binds EPO-R Y479, one group has suggested that ERK activation downstream of PI3-kinase accounts for the importance of this residue in EPO signaling. However, we show that inhibition of PI3-kinase does not abolish ERK activation. Furthermore, we demonstrate interaction of PLCgamma1 with Grb2 and SOS2. Hence, we have identified a novel adapter function for PLCgamma1 in EPO signaling in which recruitment of PLCgamma1 to EPO-R may lead to activation of the ERK pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Enzyme Activation / drug effects
  • Erythropoiesis / physiology
  • Erythropoietin / metabolism
  • Erythropoietin / pharmacology
  • Mice
  • Mitogen-Activated Protein Kinase 3 / metabolism*
  • Phosphorylation
  • Receptors, Erythropoietin / metabolism*
  • Signal Transduction* / drug effects
  • Transfection
  • src Homology Domains

Substances

  • Receptors, Erythropoietin
  • Erythropoietin
  • Mitogen-Activated Protein Kinase 3